Electrocardiographic Changes of Sinoatrial Dysfunction in Hypoglycemia: A Case Report
DOI:
https://doi.org/10.56294/shp2024398Keywords:
Sinoatrial dysfunction, sinus pause, hypoglycemiaAbstract
Acute and chronic hypoglycemia, induced by insulin or oral antidiabetic agents in a therapeutic context, is a cardiovascular risk factor that triggers endothelial dysfunction and atherogenesis via pro-inflammatory mechanisms. It may be equally or more relevant than hyperglycemia, with the added threat of inducing arrhythmogenic and ischemic sudden death.
We present the case of a 61-year-old female patient with a medical history of diabetes mellitus, managed with long-acting insulin (30 units in the morning and 15 units at night), who developed fever, general malaise, and anorexia, followed by an episode of near syncope accompanied by profuse sweating. She was taken to the emergency department, where capillary blood glucose was found to be 2.4 mmol/L. A 12-lead ECG revealed sinus pauses, which resolved following administration of hypertonic dextrose.
This case illustrates that hypoglycemia poses a real threat to the myocardium, not only due to its immediate proarrhythmic effects (linked to sudden death syndrome) but also due to its long-term proinflammatory and atherogenic effects, representing a major cardiovascular risk factor. Therefore, it is desirable and clinically pertinent to avoid hypoglycemic episodes of any intensity or duration in all diabetic patients—particularly those with underlying myocardial pathologies that increase the risk of sudden death: compromised systolic function, ventricular arrhythmias, atrial fibrillation, coronary artery disease, hypertrophic cardiomyopathy, arrhythmogenic genotype, and history of resuscitation.
References
ALAD Guidelines for the Diagnosis, Control, and Treatment of Type 2 Diabetes Mellitus Based on Evidence-Based Medicine. 2013 Edition. Rev ALAD. 2013;1–142.
Bruce DG, Davis WA, Casey GP. Severe hypoglycemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009;52:1808–1815.
ADVANCE Study. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.
Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2009;19:604–612.
ACCORD Study. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–828.
ACCORD Study. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.
Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab. 2005;7:493–503.
Fisher BM, Heller SR. Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. In: Frier BM, Fisher M, eds. Hypoglycaemia in Clinical Diabetes. 2nd ed. Chichester: John Wiley and Sons; 2007:265–283.
Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34 Suppl:S132–S137.
Chow E, Bernjak A, Williams S, Fawdry RS, Hibbert S, Freeman J, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63:1738–1747.
Lim VG, Yip KP, Lim ZY, Sporton S, Kennon S. The ‘Normal’ Heart: Fascicular Ventricular Tachycardia. Am J Med. 2016.
Rivero Ayerza M, Femenía F. Ablation of idiopathic ventricular tachycardias. In: Brugada J, Aguinaga L. Catheter Ablation of Cardiac Arrhythmias. Chapter 8.
Paraskevaidis S, Theofilogiannakos EK, Konstantinou DM, Mantziari L, Kefalidis C, Megarisiotou A, et al. Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia. Herz. 2015.
Castro Hevia J, Dorticós Balea F, Zayas Molina R, Dorantes Sánchez M, Rodríguez Marture F. Left fascicular ventricular tachycardia: report of 2 cases. Rev Cubana Cardiol Cir Cardiovasc. 1998;12(1):13–19.
Liu Y, Fang Z, Yang B, Kojodjojo P, Chen H, Ju W, et al. Catheter ablation of fascicular ventricular tachycardia: long-term clinical outcomes and mechanisms of recurrence. Circ Arrhythm Electrophysiol. 2015 Sep 18.
Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54:2056.
Meah VL, Cockcroft JR, Backx K, et al. Cardiac output and related hemodynamics during pregnancy: a series of meta-analyses. Heart. 2016;102:518.
Green LJ, Mackillop LH, Salvi D, et al. Gestation-specific reference ranges for vital signs in pregnancy. Obstet Gynecol. 2020;135:653.
Tan H, Lie K. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J. 2001;22:458–464.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Agustina Campo (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.